Señales en vivo de XLRN | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 dic 1970 @ 19:00):

Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases...

Stats
Volumen de hoy	7.88M
Volumen promedio	1.27M
Capitalización de mercado	0.00
EPS	$-1.160 ( 2021-11-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$2.64 (1.48%)

Insider Trading

Date	Person	Action	Amount	type
2021-11-19	Zakrzewski Joseph S	Sell	34 499	Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	10 000	Option to Purchase Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	7 500	Option to Purchase Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	7 500	Option to Purchase Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	10 000	Option to Purchase Common Stock

INSIDER POWER
0.00
Last 100 transactions
Buy: 155 406 \| Sell: 743 673

Volumen Correlación

Largo: 0.40 (neutral)

Corto: 0.62 (weak)

Signal:(71.182) Neutral

Acceleron Pharma Inc Correlación

10 Correlaciones Más Positivas
APAC	0.971
THCPU	0.97
WTMA	0.97
ALGN	0.966
CRUS	0.963
ALGM	0.961
ATRS	0.961
IQ	0.96
NVAC	0.96
BLDR	0.959

10 Correlaciones Más Negativas
NAKD	-0.958
PROC	-0.953
MTEX	-0.949
AHPI	-0.949
GRIN	-0.946
TRIT	-0.94
PIII	-0.938
LCAP	-0.935
CYTO	-0.935
LAWS	-0.934

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acceleron Pharma Inc Correlación - Moneda/Commodity

-0.13
( neutral )

0.62
( weak )

0.56
( weak )

0.08
( neutral )

0.21
( neutral )

0.17
( neutral )

Acceleron Pharma Inc Finanzas

Annual	2020
Ingresos:	$92.52M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.92

FY	2020
Ingresos:	$92.52M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.92

FY	2019
Ingresos:	$73.99M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.38

FY	2018
Ingresos:	$13.99M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.59

Financial Reports:

No articles found.

Acceleron Pharma Inc

Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. It offers luspatercept-aamt for the treatment of anemia in adult patients with beta-thalassemia under the REBLOZYL name. The company also develops luspatercept-aamt for the treatment of myelodysplastic syndromes and myelofibrosis; Sotatercept for the treatment of patients with pulmonary arterial hypertension; and ACE-083, a neuromuscular candidate that is in Phase II clinical trials for the treatment of patients with Charcot-Marie-Tooth disease. In addition, it has a collaboration, license, and option agreement with Celgene Corporation; and collaboration and license agreement with Fulcrum Therapeutics, Inc. to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space. The company was formerly known as Phoenix Pharma, Inc. Acceleron Pharma Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.